Development of macrolide resistance-associated mutations after macrolide treatment in children infected with Mycoplasma pneumoniae.

CONCLUSION: A macrolide-resistant population might develop in individual patients up to 24 days after initiation of macrolide treatment. However, the decrease in M. pneumoniae load after macrolide administration effectively reduces interpersonal transmission. PMID: 28984229 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28984229?dopt=Abstract

Source: Journal of Medical Microbiology - October 6, 2017 Category: Microbiology Authors: Suzuki Y, Shimotai Y, Itagaki T, Seto J, Ikeda T, Yahagi K, Mizuta K, Hongo S, Matsuzaki Y Tags: J Med Microbiol Source Type: research